Hilig, Shairah .

HRN: 23-91-90  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/28/2023
CEFUROXIME 750MG (VIAL)
11/28/2023
11/29/2023
IV
1.5gm 3 Doses
Q8
SP CS
Waiting Final Action 
11/29/2023
CEFUROXIME 500MG (TAB)
11/29/2023
12/06/2023
PO
500mg
BID X 7 Days
Thickly Meconium Stained Amniotic Fluid
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: